(R)-(+)-Nadifloxacin(160961-35-3)
- Name: (R)-(+)-Nadifloxacin
- Synonyms:1H,5H-Benzo[ij]quinolizine-2-carboxylic acid,9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (R)-;(R)-(+)-Nadifloxacin
- Molecular Formula:C19H21 F N2 O4
- Molecular Weight:360.38
- CAS Registry Number:160961-35-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.160961-35-3 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid,9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5R)-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.160961-35-3 (R)-(+)-Nadifloxacin
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.160961-35-3 (R)-Nadifloxacin
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 76393-32-3/ethyl 4-({[2-chloro-5-(trifluoromethyl)phenyl]carbamoyl}amino)benzoate
- 5487-54-7/N-(2,3-dihydro-1H-inden-5-yl)pyridine-2-carboxamide
- 20049-89-2/N-octadecyl-2-phenylhydrazinecarboxamide
- 62897-91-0/Benzene,1,1'-(2-ethylbutylidene)bis[4-methoxy-
- 23379-12-6/2-chloro-4-(fluorosulfonyl)phenyl 2-chlorobenzoate
- 67464-81-7/Ethyl 2-(cyanoMethyl)-1H-pyrrole-3-carboxylate
- 101453-70-7/potassium 3-hydroxy-7-methoxy-N-(o-tolyl)naphthalene-2-carboxamide
- 7507-56-4/2-[(3-cyclohexyl-3-hydroxy-2-phenylpropanoyl)oxy]-N,N-diethyl-N-methylethanaminium
- 93804-40-1/Benzenesulfonic acid, 2-[2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-5-[[4-(4-morpholinyl)-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, sodium salt, compd. with 2,2'-iminobis[ethanol] (9CI)
- 84878-36-4/cadmium isooctadecanoate
- 6957-58-0/1-amino-9H-fluoren-9-ol
- 81241-65-8/2-[(2E)-butan-2-ylideneamino]ethanol
- 89901-02-0/METHYL 4'-CHLORO[1,1'-BIPHENYL]-4-CARBOXYLATE
- 91051-19-3/Fatty acids, linseed-oil, reaction products with diethylenetriamine
- 23042-47-9/N-methyl-2-nitro-4-phenoxy-aniline
- 67239-21-8/5,9,10,14b-Tetrahydro-5,10-dimethylisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one
- 56456-52-1/4-(Trifluoromethylthio)benzyl alcohol
- 27301-50-4/3-benzyl-5-(4-chlorophenyl)-1,4-diphenyl-1H-pyrazole
- 95465-78-4/Alcohols, C6-20, C12-18-rich, reaction products with ammonia-diethylene glycol reaction products morpholine deriv. residues and epichlorohydrin
- 160961-35-3/(R)-(+)-Nadifloxacin
- 5475-01-4/methyl 4-(4-ethoxy-3-methoxyphenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
- 5430-39-7/[3-acetyl-4-(methoxycarbonyl)phenyl]arsonic acid
- 5261-32-5/4-[(4-benzylpiperidin-1-yl)methyl]-2-ethoxyphenol
- 143483-77-6/33-[(3,6-dideoxy-3-{[(4-methylpiperazin-1-yl)acetyl]amino}hexopyranosyl)oxy]-N-[2-(dimethylamino)ethyl]-1,3,5,7,9,13,37-heptahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta
- 110392-55-7/[2,2-Bis[(2-prophenyloxy)methyl]-1-butanolato-O,O′,O″]-tris(isooctanolato)-zirconium
- 40674-86-0/Iron,tricarbonyl[(1,2,3,4-h)-1,3-cycloheptadiene]-
- 55984-52-6/2-[methyl(nitroso)amino]-1-phenylethanone
- 93803-47-5/methyl N,N,N-trimethyl[(2-hydroxy[1,1'-biphenyl]-3-yl)methyl]ammonium sulphate
- 5569-40-4/1-methyl-4-(tricyclo[3.3.1.1~3,7~]dec-1-ylsulfinyl)piperazine
- 96690-81-2/Zirconium, Bu alc. C16-18-fatty acid Et acetoacetate complexes